This week’s Lattice Brief asks where 3D printing actually makes money: the listed printer makers lose money, while treatments with printing inside, medical software, consumables ecosystems and clinically priced devices earn the margins. Also inside: FDA clears a 3D printed porous titanium cervical system, an ARPA-H liver bioprinting award, robotic bioprinting for diabetic wounds, and the VDMA autumn survey. The Lattice Brief returns the week of November 2.
The big thing
Where 3D printing actually makes money
The industry feels better. VDMA’s autumn survey says 64% of German additive manufacturing firms grew sales over the past year, up from 45% a year ago. But costs still top their worries. Growth is not the same as profit.
Look at the listed printer makers. In Q2, Stratasys lost $16.9M and 3D Systems lost $12.9M. Creality grew first-half revenue 13% and still swung to a loss. Digital manufacturers do a little better: Proto Labs earned $9.2M, while its 3D printing revenue slipped and its CNC and molding grew.
Against sector benchmarks, the pattern is clear. Printer makers earn machinery-level gross margins but post losses. 3D printing companies beat their sector mainly in medicine.
The profits sit in four places.
Treatments with printing inside. Align prints a mold for every Invisalign tray and posted a 71.7% gross margin in Q2. The printer is a cost line, not the product.
Medical software and services. Materialise’s medical segment earned a 31.3% adjusted EBITDA margin. The whole company earned 5.5%.
Ecosystems that sell consumables. Formlabs says it has been profitable for two years. Creality’s consumables grew 48% while printer sales were flat.
Devices priced on clinical value. Stryker has printed more than two million Tritanium implants, and its orthopaedics segment ran a 34% operating margin.
My view: margin follows the patient, not the machine. Price the outcome, own the consumable, and secure payment early. That is why Trio Labs sells finished medical parts, not printers, as founder Adam Steege explains on Episode 130.
Read the full analysis on where profitability is, with the benchmarks, and leading public companies, ending with an FAQ. Which business model would you back? Better ideas?
Hit reply and tell us.
A note from Jenny: I’m taking a few weeks of vacation. The Lattice Brief will be back on its normal schedule the week of November 2. Thank you for reading.
From 3DHEALS
- Which 3D Printing Businesses Are Profitable? A Healthcare Focus in 2026. The full analysis behind this week’s big thing: sector benchmarks, Stryker, Xometry and Proto Labs, four profitable business models, and an FAQ.
- Episode 130: 3D Print Tiny Things with Adam Steege, Trio Labs. Why Trio sells finished micron-scale metal parts for medical devices instead of printers, and when printing beats CNC and metal injection molding.
- 3D Printed Drugs Guide (updated October 2026). Background for this week’s PharmaTher and St. Jude items: processes, players, evidence and the new point-of-care rules.
Regulatory watch
- FDA clears Providence Medical’s 3D printed porous titanium cervical system (ODT Magazine, Oct 13). A 510(k) for CORUS PCSS 3D-T, a printed porous titanium version of its posterior cervical stabilization system. Same design and indications; the lattice is meant to support bone ingrowth.
- ARPA-H awards Terasaki Institute up to $19.8M to bioprint liver tissue (EurekAlert!, Oct 2). The PRINT program’s Prometheus project combines stem-cell-derived liver cells, bioreactor culture and bioprinting to make tissue that avoids immune rejection. A catch-up item we missed two weeks ago.
Clinical & research
- Bioprinted scaffolds for leg ulcers: a systematic review of clinical trials (Frontiers in Bioengineering and Biotechnology, via PubMed). University of Hong Kong authors found 8 clinical studies with 139 patients. Both randomized trials showed faster complete healing than standard dressings, with no treatment-related serious adverse events. The studies are small with short follow-up.
- Custom 3D printed shoulder prostheses after tumor resection: 30 patients at three years (Journal of Shoulder and Elbow Surgery, via PubMed). Sun Yat-sen University Cancer Center reports mean functional scores of 84% (MSTS) and 85% (ASES) at a mean 37.7 months, with one loosening and two plate exposures. Retrospective, single center.
- Vision-guided robotic bioprinting onto diabetic wounds (Advanced Functional Materials, via PubMed). A Brigham and Women’s / Harvard team paired an oxygen-releasing stem-cell bioink with an autonomous robot that prints directly onto the wound. In animal models it sped closure. Physical AI meets bioprinting.
Also this week
Point of care and pharmacy
- How a Dutch trauma center built a roadmap for printing splints in house (3D Printing in Medicine, via Bioengineer.org). Radboudumc mapped technical, workflow and regulatory barriers, with owners for each.
- PharmaTher launches a national network of pharmacy printing sites (3D Printing Industry). Starts with US 503A compounding pharmacies; it will seek emergency-readiness contracts. A follow-up to last week’s big thing.
- 3D printing and automated compounding in pediatric pharmacy (Journal of Pediatric Pharmacology and Therapeutics, via PubMed). St. Jude Children’s Research Hospital pharmacy authors on bringing both into pediatric practice.
- 3D reconstruction beats 2D imaging for pediatric kidney surgery planning (VoxelMatters). Turin, 8 children. The models were virtual, not printed; the team cited cost.
Devices and dental
- IMDEA and UPM print braided nitinol for transcatheter devices (VoxelMatters). One-step braided stents recovered over 90% after compression to half their diameter.
- SprintRay adds a scanner and compact chairside print line (Med-Tech Insights). Foundation scanner and Nano Series ship from November, subject to regional approvals.
- GC launches a hybrid ceramic resin for SprintRay’s Midas press (PR Newswire). For permanent crowns, inlays, onlays and veneers; US availability from Nov 1.
- Limber Prosthetics sells a printed leg from $3,000 (Hoodline). Smartphone scan, one-piece print in about 12 hours; about 800 devices made, per the company.
Research
- Support-bath bioprinting keeps mature human fat cells alive (Bioengineer.org). University of Stuttgart; a step toward better fat-tissue models for metabolic disease.
Industry and tools
- VDMA autumn survey: business improves, expectations cautiously positive (VDMA). 64% of German AM firms grew sales; medical technology is among the fastest-growing applications.
- UC Berkeley releases OpenCAL, an open-source volumetric printer (VoxelMatters). About $1,638 in parts, with resin from Formlabs and Prusa.
- NVIDIA open-sources a CAD modeling kernel (3D Printing Industry). USD BRep, Apache 2.0; a building block for AI-assisted design.
- A roller coaster, kidney stones and ultrasound: a decade later (Medical Daily). How a 3D printed kidney model on a Disney ride led to ultrasound devices for stones.
Get The Lattice Brief every week. We are back the week of November 2.
Subscribe to The Lattice Brief
Want to sponsor this newsletter? Contact us
Comments